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Not just UV
Individuals with the “red hair/fair skin” phenotype, which car-
ries the highest risk for melanoma development, typically harbor 
inactivating mutations in the melanocortin 1 receptor (MC1R) 
gene, whose low activity produces pheomelanin. Because some 
evidence suggests that UV radiation–independent mechanisms 
may also be at play in melanoma risk, Mitra and colleagues 
inserted a conditional, melanocyte-targeted allele of the most 
common melanoma oncoprotein BRAFV600E in mice with an 
inactive Mc1r gene and consequent “red hair/fair skin” pheno-
type to explore UV-independent melanomagenesis. Interestingly, 
these mice exhibited an increased risk of malignant melano-
ma in the absence of UV exposure. Introduction of the albino 
tyrosinase allele resulted in protection from melanoma, and the 
transgenic mice displayed greater oxidative DNA and lipid dam-
age than did albino mutant mice, indicating that pheomelanin 
is intrinsically involved in carcinogenesis, in part via oxidative 
damage. Thus, UV protection, albeit important, may guard the 
skin against only one of several carcinogenic mechanisms. 
(Nature 491:449–53, 2012) Selected by T. Schwarz
The first seven years
Mutations in the filaggrin gene (FLG), which occur in approxi-
mately 10% of the population, are major predisposing factors 
for atopic dermatitis (AD). Because these mutations are also 
associated with early onset, persistence of AD into adulthood, 
and asthma and allergic sensitization, Carson and colleagues 
characterized the pattern of AD in the Copenhagen Prospective 
Birth Cohort (a prospective clinical birth cohort of 411 children 
born to mothers with asthma, followed for the first seven years 
of life) to examine stratification by FLG mutation status. Overall, 
the study revealed that the FLG null-driven AD endotype was 
associated with AD at exposed anatomical localizations, such 
as the hands and cheeks. The endotype was also character-
ized by early onset of disease and a more severe course with 
more generalized dermatitis, as evidenced by more frequent 
medical visits. Thus, endotyping of AD via FLG null mutation 
phenotype may be useful for stratifying patients and developing 
individualized treatment possibilities. (PLoS ONE 7:e48678, 
2012) Selected by H. Williams
Looking downstream
Mutations in PTEN, a phosphatase implicated in heritable can-
cer syndrome as well as in many sporadic cancers, have been 
identified in 25% of cases of the difficult-to-diagnose Cowden’s 
syndrome (CS), which carries high risk for breast, thyroid, and 
other cancers. Orloff and colleagues sequenced the PTEN 
downstream genes AKT1, PIK3CA, PIK3R1, and PIK3R2 in 
individuals with CS who did not carry PTEN mutations (or 
alterations in the other previously implicated genes, SDHx and 
KLLN). Interestingly, 11% of these individuals carried germline 
gain-of-function AKT1 or PIK3CA mutations. Protein modeling 
predicted structural alterations in these mutant proteins, and 
western blot analysis of cell lysates revealed increased phos-
phorylated AKT1 levels and increased PIP3 levels. Together, 
these findings suggest that PIK3CA and AKT1 genes are CS sus-
ceptibility genes and that additional studies of these pathways 
may facilitate better diagnosis and treatment of CS. (Am J Hum 
Genet 92:76–80, 2013) Selected by J. Uitto
Splicing hairs
Hypotrichosis simplex (HS) has been attributed to muta-
tions in six genes in several families with autosomal-dom-
inant HS, but a large number of families and simplex cases 
remain unexplained. Pasternack and colleagues performed a 
genome-wide linkage analysis study of 12 family members, 
including 6 affected individuals, and identified the marker 
DIS1660 in a candidate region comprising more than 100 
annotated genes. Careful gene-by-gene sequence analysis 
revealed mutations in SNRPE, a gene that encodes a core 
protein of pre-mRNA processing U-rich small nuclear ribonu-
cleoproteins (U snRNPs) critical for the spliceosome, in cases 
from Spain, the United Kingdom, and Tunisia. The mutations, 
which probably alter the protein structure, resulted in correct-
ly expressed and localized protein; however, because of the 
potential effects on solubility, the function of SNRPE is likely 
compromised in these cases. These results highlight the func-
tion of a spliceosomal snRNP in a specific hair phenotype. 
(Am J Hum Genet 92:81–7, 2013) Selected by J. Uitto
As old as the hills
Recently, loss-of-function mutations in the FLG gene, which 
is involved in skin barrier function, were identified in AD, 
underscoring the role of the skin barrier in concert with 
chronic immune activation in the pathogenesis of AD. 
Although treatment of AD is typically aimed at alleviating 
symptoms, coal tar has been used to treat skin diseases 
for more than 2,000 years despite a complete lack of 
understanding of its mechanism of action. Coal tar contains 
polycyclic aromatic hydrocarbons that are metabolized by 
keratinocytes via CYP450 enzymes, which are induced via 
the aryl hydrocarbon receptor (AHR). In studies of coal tar 
exposure on the epidermis in cultured keratinoctyes and skin 
models, van den Bogaard and colleagues found that coal 
tar activated AHR and consequently accelerated epidermal 
differentiation. Moreover, coal tar restored expression of 
filaggrin in mutant cells and interfered with Th2 cytokine 
signaling. Thus, these findings may justify reappraisal (or at 
least further exploration) of this historic skin disease treatment 
agent. (J Clin Invest, published online 25 January 2013; 
doi:10.1172/JCI65642) Selected by L. Beck
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